These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10961808)

  • 61. 1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells.
    Kulbersh JS; Day TA; Gillespie MB; Young MR
    Otolaryngol Head Neck Surg; 2009 Feb; 140(2):235-40. PubMed ID: 19201295
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Circulating Proteasomes in the Pathogenesis of Head and Neck Squamous Cell Carcinoma.
    Kakurina GV; Cheremisina OV; Choinzonov EL; Kondakova IV
    Bull Exp Biol Med; 2017 May; 163(1):92-94. PubMed ID: 28577090
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The doubtful relevance of nonspecific immune reactivity in patients with squamous cell carcinoma of the head and neck region.
    Bier J; Nicklisch U; Platz H
    Cancer; 1983 Oct; 52(7):1165-72. PubMed ID: 6603897
    [TBL] [Abstract][Full Text] [Related]  

  • 64. T-lymphocytes as a prognostic indicator in head and neck cancer.
    Schuller DE; Rock RP; Rinehart JJ; Koolemans-Beynen AR
    Arch Otolaryngol Head Neck Surg; 1986 Sep; 112(9):938-41. PubMed ID: 3488752
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immune suppression in head and neck cancers: a review.
    Duray A; Demoulin S; Hubert P; Delvenne P; Saussez S
    Clin Dev Immunol; 2010; 2010():701657. PubMed ID: 21437225
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro T-lymphocyte function in head and neck cancer patients.
    Heimdal JH; Aarstad HJ; Aakvaag A; Olofsson J
    Eur Arch Otorhinolaryngol; 1997; 254(7):318-22. PubMed ID: 9298666
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An immunologic profile of young adults with head and neck cancer.
    Schantz SP; Liu FJ
    Cancer; 1989 Sep; 64(6):1232-7. PubMed ID: 2569924
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lymphocyte response to phytohaemagglutinin before and after radiation therapy in patients with carcinomas of the head and neck.
    Stefani SS; Kerman RH
    J Laryngol Otol; 1977 Jul; 91(7):605-9. PubMed ID: 302294
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinical significance of the subsets of lymphocyte in the peripheral blood of the head and neck cancer patients].
    Okamoto M; Takahashi H; Yao K; Fujino A; Ishii T; Harada K; Yagi A; Yoshio S; Yagi K; Furusawa S
    Nihon Jibiinkoka Gakkai Kaiho; 1985 Apr; 88(4):443-8. PubMed ID: 4032110
    [No Abstract]   [Full Text] [Related]  

  • 70. [Quantitative analysis of activated T-lymphocytes by virus plaque assay in patients with head and neck cancer (author's transl)].
    Takenaka H; Hoshino A; Miyoshi S; Kida H; Saito H; Mizukoshi O; Amagai T
    Nihon Jibiinkoka Gakkai Kaiho; 1979 Jul; 82(7):674-81. PubMed ID: 317104
    [No Abstract]   [Full Text] [Related]  

  • 71. Immunosuppressive retroviral-related factors in sera of patients with head and neck cancer.
    Tan IB; Balm AJ; Snow GB; Drexhage HA
    Eur Arch Otorhinolaryngol; 1990; 247(6):387-90. PubMed ID: 2278707
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intraepithelial ILC1-like cells: Front-line fighters in human head and neck squamous cell carcinoma.
    Cella M; Robinette ML
    Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34376560
    [No Abstract]   [Full Text] [Related]  

  • 73. A mechanism for esophageal tumor-derived immunosuppression.
    Shanahan F
    Gastroenterology; 1994 Jun; 106(6):1717-8. PubMed ID: 8194725
    [No Abstract]   [Full Text] [Related]  

  • 74. Induction of M-MDSCs with IL6/GM-CSF from adherence monocytes and inhibition by WP1066.
    Hu H; Xiang Y; Li T; Yu QY; Gu LX; Liao XH; Zhang TC
    Exp Ther Med; 2022 Jul; 24(1):487. PubMed ID: 35761803
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia.
    Zahran AM; Shibl A; Rayan A; Mohamed MAEH; Osman AMM; Saad K; Mahmoud KH; Ghandour AMA; Elsayh KI; El-Badawy O
    Sci Rep; 2021 Jul; 11(1):15039. PubMed ID: 34294814
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vitamin D deficiency in head and neck cancer patients - prevalence, prognostic value and impact on immune function.
    Bochen F; Balensiefer B; Körner S; Bittenbring JT; Neumann F; Koch A; Bumm K; Marx A; Wemmert S; Papaspyrou G; Zuschlag D; Kühn JP; Al Kadah B; Schick B; Linxweiler M
    Oncoimmunology; 2018; 7(9):e1476817. PubMed ID: 30228945
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Myeloid derived suppressor cells in chronic myeloid leukemia.
    Giallongo C; Parrinello N; Brundo MV; Raccuia SA; Di Rosa M; La Cava P; Tibullo D
    Front Oncol; 2015; 5():107. PubMed ID: 26029664
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.
    Freiser ME; Serafini P; Weed DT
    Immunol Res; 2013 Dec; 57(1-3):52-69. PubMed ID: 24218361
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immune regulatory activity of vitamin d3 in head and neck cancer.
    Young MR; Day TA
    Cancers (Basel); 2013 Aug; 5(3):1072-85. PubMed ID: 24202334
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer.
    Wittekindt C; Wagner S; Mayer CS; Klussmann JP
    GMS Curr Top Otorhinolaryngol Head Neck Surg; 2012; 11():Doc09. PubMed ID: 23320061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.